In our recent whole‐genome sequencing study on 70 NPCs, we uncovered that NPC patients with somatic defects in DDR genes (TP53, ATM, BRCA1 and BRCA2) had significantly shorter survival rates than those with null mutation (KWL, unpublished observation). The gene discussed is BRCA1; the disease is nasopharyngeal carcinoma.